CCM
PFE icon

Cinctive Capital Management’s Pfizer PFE Stock Holding History

Cinctive Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,828
Closed -$894K – 525
2026
Q1 		$894K Buy
+31,828
New +$847K 0.06% 265
2025
Q4 		– Sell
-459,455
Closed -$11.7M – 493
2025
Q3 		$11.7M Buy
459,455
+309,009
+205% +$7.63M 0.56% 47
2025
Q2 		$3.65M Sell
150,446
-26,292
-15% -$613K 0.19% 157
2025
Q1 		$4.48M Sell
176,738
-4,564
-3% -$119K 0.34% 95
2024
Q4 		$4.81M Buy
181,302
+12,060
+7% +$327K 0.24% 135
2024
Q3 		$4.9M Sell
169,242
-374,035
-69% -$10.9M 0.27% 123
2024
Q2 		$15.2M Buy
543,277
+405,811
+295% +$11.2M 0.72% 28
2024
Q1 		$3.81M Buy
137,466
+123,638
+894% +$3.43M 0.18% 158
2023
Q4 		$398K Buy
+13,828
New +$418K 0.03% 323
2022
Q2 		– Sell
-82,466
Closed -$4.27M – 606
2022
Q1 		$4.27M Sell
82,466
-14,474
-15% -$751K 0.16% 212
2021
Q4 		$5.72M Buy
+96,940
New +$4.8M 0.25% 128

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cinctive Capital Management's PFE Position: Q2 2026 in Review

Cinctive Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 31,828 shares — an estimated $894K sold.

Cinctive Capital Management first reported a position in PFE in Q4 2021 and held it in 11 quarters. The position peaked at $15.2M in Q2 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cinctive Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 31,828 Pfizer shares in Q2 2026, an estimated $894K.
  • Cinctive Capital Management first reported a position in Pfizer in Q4 2021 and held it in 11 quarters.
  • Cinctive Capital Management's Pfizer position peaked at $15.2M in Q2 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.